2018 Annual General Meeting podcast
NOX 2018 AGM Presentations
Noxopharm Releases Latest Corporate Presentation
Noxopharm (ASX:NOX) Presentation, FNN Investor Event, 15 Aug 2018, Sydney
Noxopharm (ASX:NOX) update on NOX66 and radiotherapy trials
NOX Corporate Presentation FNN-Shaw&Partners Investor Event
Noxopharm Corporate Presentation for Public Briefing
Noxopharm CEO Interview Updates the Company's Current Research and Development Program
Noxopharm CEO Interview on near-completed NOX66 chemotherapy trial CEP-1
Noxopharm CEO Interview with FNN on the Company's NOX66 and Radiotherapy Clinical Programs